Sep 13, 2021 / 05:15PM GMT
Yih-Ming Tu - Morgan Stanley, Research Division - Research Associate
Good afternoon, everyone. Welcome to day 3 of our Morgan Stanley Global Healthcare Conference. My name is Edmund Tu, and I'm on the life science tools and diagnostics team here at Morgan Stanley. And I'm very excited to have Henry Schein with me this morning. Representing the company, I have Mr. Stanley Bergman, CEO; Mr. Steven Paladino, CFO; and Ms. Erin Sekula, Director of Investor Relations. Thank you guys for joining today.
Stanley M. Bergman - Henry Schein, Inc. - Executive Chairman & CEO
Steve, you're on mute.
Steven Paladino - Henry Schein, Inc. - Executive VP, CFO & Executive Director
Okay. Hello, everyone. Thank you, Edmund. Before we begin, I just wanted to say that certain comments made during this call may include forward-looking information. As you know, risks and uncertainties involved in the company's business may affect those matters referred to in the forward-looking statements. As a result, the company's
Henry Schein Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot